A worldwide study called Strategic Timing of Antiretroviral Therapy (START), supported by the National Institutes of Health, proved that it's better to treat HIV early, while a person's CD4+ T-cell count is still high.
Source: START trial results. New England Journal of Medicine 2015.
A review of the START study found that when people with HIV were treated early, while their CD4+ T-cell count was still high, the risk of having a serious HIV- or non-HIV-related illness, or dying from any cause, was decreased by 57%.
HIV treatment may lower a person's viral load. When this happens, there's less of a chance that someone who's HIV-positive will pass the virus to someone else.
People with HIV who are on HIV treatment, and have their viral load decreased, are now living longer.
Starting HIV treatment will help to lower the amount of virus in my blood and increase the number of CD4+ T-cells.
I am up to the task of taking HIV medicines each day.
I am comfortable discussing my HIV with my healthcare provider.
I know there could be side effects, but I can deal with that possibility.
I feel that I have a good understanding of the HIV treatment options available.
You’re on the right path.
It looks like you’re ready to learn more about treatment. See how other people went through the process of deciding to start treatment.
This quiz is not intended to diagnose a condition or disease state and does not replace the advice of your healthcare provider. Please partner with your healthcare provider to determine if starting HIV treatment is the right choice for you.
YOU ARE ABOUT TO LEAVE A ViiV HEALTHCARE WEB SITE.
By clicking this link, you will be taken to a Web site that is independent from ViiV Healthcare. The site you are linking to is not controlled or endorsed by ViiV Healthcare, and ViiV Healthcare is not responsible for the content provided on that site.